Sapient Featured in Deloitte’s xTech Futures: BioTech Report

The report showcases exponential technologies in biotechnology likely to change the way our world works and lives.

How deep immune phenotyping via small molecule biomarkers could change the way we diagnose and treat autoimmune diseases

How small molecule biomarkers can help decipher autoimmune disease dynamics and inform drug development strategies.

Target Metabolite Panels and Lipid Panels for Focused Biomarker Discovery

See how Sapient enables focused biomarker discovery analyses with rapid time-to-insight.

Sapient Launches Target Metabolite and Lipid Panels for Focused Biomarker Discovery Analyses with Rapid Time-to-Insight

These ready-to-order panels speed time-to-insight through targeted exploration of known molecules.

Bioinformatics CRO Podcast: On novel biomarker discovery technologies

A discussion at the intersection of high throughput biomarker profiling, advanced data analytics, and biological insight.

Discovery of TE & PD biomarkers to advance antibody-drug conjugate (ADC) development

Explore how dynamic biomarkers of target engagement and PD can help decipher the heterogeneity of ADCs and their targets.

Discovery of a Biomarker of Biological Processes for Rare Disease

This case study details the discovery of a biomarker of biological processes in patients with sequence-verified mitochondrial disease.